Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medical Economic Analysis of the Interest of Hepcidin Quantitation by Quantitative Mass Spectrometry for the Diagnosis of Iron Deficiency in Anemic Critically Ill Patients

NCT02276690 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02276690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02276690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medical Economic Analysis of the Interest of Hepcidin Quantitation by Quantitative Mass Spectrometry for the Diagnosis of Iron Deficiency in Anemic Critically Ill Patients
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
September 30, 2017
Enrollment
408 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, critical illness, hospitalized for 5 days or more